Michela Chiappa - Mario Negri Institute for Pharmacological Research

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background

Michela Chiappa,Federica Guffanti,Chiara Grasselli,Nicolo Panini,Alessandro Corbelli,Fabio Fiordaliso,Giovanna Damia

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 5 (2024)

引用0浏览0WOS引用

In Vivo Anti-Tumor Activity of Onvansertib, a PLK1 Inhibitor, Combined with Gemcitabine or Carboplatin in Platinum- Resistant Ovarian Carcinoma Patient-Derived Xenograft Models

Michela Chiappa,Federica Guffanti, Ilaria Mengoli,Maya Ridinger,Giovanna Damia

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Abstract 945: in Vivo Anti-Tumor Activity of Onvansertib, a PLK1 Inhibitor, Combined with Gemcitabine or Carboplatin in Platinum- Resistant Ovarian Carcinoma Patient-Derived Xenograft Models

Michela Chiappa,Federica Guffanti, Ilaria Mengoli,Maya Ridinger,Giovanna Damia

Cancer Researchno. 6_Supplement (2024): 945-945

引用0浏览0引用

Onvansertib Treatment Overcomes Olaparib Resistance in High-Grade Ovarian Carcinomas

Michela Chiappa,Alessandra Decio,Luca Guarrera, Ilaria Mengoli,Anju Karki, Divora Yemane,Carmen Ghilardi,Eugenio Scanziani,Simone Canesi, Maria C. Barbera,Ilaria Craparotta,Marco Bolis,Robert Fruscio,Chiara Grasselli,Tommaso Ceruti,Massimo Zucchetti,Jesse C. Patterson, Robin A. Lu, Micheal B. Yaffe,Maya Ridinger,Giovanna Damia,Federica Guffanti

CELL DEATH & DISEASEno. 7 (2024)

引用0浏览0WOSNATURE引用

Additional File 1 of Isolation and Characterization of Two Newly Established Thymoma PDXs from Two Relapses of the Same Patient: a New Tool to Investigate Thymic Malignancies

Paolo Mendogni,Roberta Affatato,Enrico Cabri,Michela Chiappa,Gloriana Ndembe,Davide Tosi,Alessandro Del Gobbo,Maddalena Fratelli,Eleonora Pardini, Iacopo Petrini,Lorenzo Rosso,Massimo Broggini,Mirko Marabese

Figshare (2023)

引用0浏览0引用

Bcl-2 Family Inhibitors Sensitize Human Cancer Models to Therapy

Elisabetta Valentini,Marta Di Martile, Matteo Brignone, Marica Di Caprio,Isabella Manni,Michela Chiappa,Ilaria Sergio,Martina Chiacchiarini,Chiara Bazzichetto,Fabiana Conciatori,Simona D’Aguanno,Carmen D’Angelo,Rino Ragno,Michelangelo Russillo,Gianni Colotti,Francesco Marchesi,Maria Laura Bellone,Fabrizio Dal Piaz,Maria Pia Felli,Giovanna Damia,Donatella Del Bufalo

Research Square (Research Square) (2023)

引用1浏览0WOSNATURE引用

Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts (vol 126, pg 122, 2022 )

F. Guffanti,M. F. Alvisi,A. Anastasia,F. Ricci,M. Chiappa,A. Llop-Guevara,V. Serra,R. Fruscio,A. Degasperi,S. Nik-Zainal,M. R. Bani,M. Lupia,R. Giavazzi,E. Rulli,G. Damia

BRITISH JOURNAL OF CANCERno. 7 (2023): 1405-1405

引用0浏览0引用

Improving Responses to Dual PI3K/BCL2 Inhibition in Lymphomas: Results of a Pharmacological Screen with over 1,400 Compounds

A. Arribas,M. Chiappa,S. Napoli,E. Cannas,L. Cascione,F. Spriano,C. Tarantelli, D. Rossi,E. Zucca,A. Alimonti,A. Stathis,G. Damia,M. Broggini,F. Bertoni

European journal of cancer（2022）

引用0浏览0引用

Large pharmacological screen to improve responses to dual PI3K/BCL2 inhibition in lymphomas

A. J. Arribas,M. Chiappa,S. Napoli,E. Cannas,L. Cascione,F. Spriano,C. Tarantelli, D. Rossi,E. Zucca,A. Alimonti,A. Stathis,G. Damia,M. Broggini,F. Bertoni

SWISS MEDICAL WEEKLY (2022): 29S-30S

引用0浏览0引用

Abstract 3237: Combining PARP Inhibition with the Polo-Like Kinase 1 (PLK1) Inhibitor Onvansertib Overcomes PARP Inhibitor Resistance

Michela Chiappa,Federica Guffanti,Alessandra Decio, Alessandro Aliverti,Francesca Ricci,Eugenio Scanziani, Federica Camin,Ilaria Craparotta,Maria Chiara Barbera,Marco Bolis,Maya Ridinger,Giovanna Damia

Cancer researchno. 12_Supplement (2022): 3237-3237

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn